MENU
+Compare
MNKD
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$5.93
Change
-$0.00 (-0.00%)
Capitalization
1.82B

MNKD MannKind Corp Forecast, Technical & Fundamental Analysis

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension... Show more

Industry: #Biotechnology
MNKD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MNKD with price predictions
Dec 24, 2025

Momentum Indicator for MNKD turns positive, indicating new upward trend

MNKD saw its Momentum Indicator move above the 0 level on November 25, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned positive. In of the 89 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for MNKD just turned positive on November 26, 2025. Looking at past instances where MNKD's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

MNKD moved above its 50-day moving average on December 01, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MNKD crossed bullishly above the 50-day moving average on December 05, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MNKD advanced for three days, in of 254 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 186 cases where MNKD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MNKD moved out of overbought territory on December 19, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where MNKD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNKD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MNKD broke above its upper Bollinger Band on December 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MNKD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (26.541). P/E Ratio (59.300) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (5.817) is also within normal values, averaging (311.015).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
MNKD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MNKD is expected to report earnings to fall 69.86% to 2 cents per share on March 03

MannKind Corp MNKD Stock Earnings Reports
Q4'25
Est.
$0.02
Q3'25
Beat
by $0.05
Q2'25
Est.
$0.05
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.05
The last earnings report on November 05 showed earnings per share of 7 cents, beating the estimate of 1 cents. With 907.37K shares outstanding, the current market capitalization sits at 1.82B.
A.I. Advisor
published General Information

General Information

a developer of therapeutic products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Casper Street
Phone
+1 818 661-5000
Employees
414
Web
https://www.mannkindcorp.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THPMX14.910.08
+0.54%
Thompson MidCap
ACERX10.780.04
+0.37%
Invesco Equity and Income C
ITEIX10.760.03
+0.28%
VY® T. Rowe Price Equity Income I
NWCAX51.020.08
+0.16%
Nuveen Winslow Large-Cap Growth ESG A
BRXBX17.16N/A
N/A
MFS Blended Research Intl Eq B

MNKD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with IONS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
N/A
IONS - MNKD
48%
Loosely correlated
+0.40%
VCYT - MNKD
44%
Loosely correlated
-0.35%
INSM - MNKD
40%
Loosely correlated
+0.37%
DAWN - MNKD
37%
Loosely correlated
-0.31%
UTHR - MNKD
37%
Loosely correlated
+0.82%
More